Litcius/Paper detail

Tofacitinib and risk of cardiovascular outcomes: results from the Safety of TofAcitinib in Routine care patients with Rheumatoid Arthritis (STAR-RA) study

Farzin Khosrow‐Khavar, Seoyoung C. Kim, Hemin Lee, Su Been Lee, Rishi Desai

2022Annals of the Rheumatic Diseases163 citationsDOIOpen Access PDF

Topics & Concepts

TofacitinibMedicineRheumatoid arthritisInternal medicineDermatologyIntensive care medicineRheumatoid Arthritis Research and TherapiesStreptococcal Infections and TreatmentsSpondyloarthritis Studies and Treatments
Tofacitinib and risk of cardiovascular outcomes: results from the Safety of TofAcitinib in Routine care patients with Rheumatoid Arthritis (STAR-RA) study | Litcius